Beverley practises in all areas of intellectual property litigation with a focus on patent litigation and actions under the Patented Medicines (Notice of Compliance) Regulations.
She also advises clients on IP Regulatory issues such as listing patents on the Patent Register, and reporting patents to the Patented Medicines Prices Review Board, Certificates of Supplementary Protection and the Register of Innovative Drugs as it relates to data protection.
Beverley consults on the implementation and application of the intellectual property provisions of Canada’s trade agreements, including the Comprehensive Economic and Trade Agreement (CETA) between Canada and the European Union and the United States-Mexico-Canada Agreement (USMCA).
In addition, Beverley advises on patent portfolio management, patentability, validity and freedom-to-operate issues, and aids in the prosecution of patent applications in Canada.
Beverley advises on Access to Information requests, in particular those made to Health Canada by pharmaceutical clients.
Beverley has been an advocate before the Federal Courts, the Patented Medicine Prices Review Board and the Supreme Court of Canada.
Within BLG, Beverley serves on our Thought Leadership Committee, which seeks out innovative ideas to leverage within the firm.